Literature DB >> 7743464

Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

P Guinot1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7743464     DOI： 10.1007/BF02802302

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  60 in total

1.  Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia.

Authors:  R T Dobrowsky; R D Voyksner; N C Olson
Journal:  Am J Physiol       Date:  1991-05

Review 2.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

3.  Attenuation of burn-induced changes in hemodynamics and glucose metabolism by the PAF antagonist SRI 63-675.

Authors:  C Lang; C Dobrescu
Journal:  Eur J Pharmacol       Date:  1988-11-01       Impact factor: 4.432

4.  Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

Authors:  P Bessin; J Bonnet; D Apffel; C Soulard; L Desgroux; I Pelas; J Benveniste
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

5.  Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

Authors:  R Rabinovici; T L Yue; M Farhat; E F Smith; K M Esser; M Slivjak; G Feuerstein
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

6.  Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.

Authors:  S R McColl; E Krump; P H Naccache; P E Poubelle; P Braquet; M Braquet; P Borgeat
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

7.  Protection of platelet-activating factor-induced acute renal failure by BN 52021.

Authors:  E Pirotzky; P Colliez; C Guilmard; J Schaeverbeke; J M Mencia-Huerta; P Braquet
Journal:  Br J Exp Pathol       Date:  1988-04

8.  Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.

Authors:  L M Kuitert; K P Hui; S Uthayarkumar; W Burke; A C Newland; S Uden; N C Barnes
Journal:  Am Rev Respir Dis       Date:  1993-01

Review 9.  Is there a case for PAF antagonists in the treatment of ischemic states?

Authors:  P Braquet; M Paubert-Braquet; M Koltai; R Bourgain; F Bussolino; D Hosford
Journal:  Trends Pharmacol Sci       Date:  1989-01       Impact factor: 14.819

Review 10.  Multiple sclerosis: possible immunological mechanisms.

Authors:  H F McFarland; S Dhib-Jalbut
Journal:  Clin Immunol Immunopathol       Date:  1989-01
View more
  2 in total

Review 1.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway.

Authors:  Kohei Kawasaki; Atsushi Kasamatsu; Toshiaki Ando; Tomoaki Saito; Takafumi Nobuchi; Ryunosuke Nozaki; Manabu Iyoda; Katsuhiro Uzawa
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.